Stock 600285 HENAN LINGRUI PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Henan Lingrui Pharmaceutical Co., Ltd.

Equities

600285

CNE000001501

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
25.3 CNY +8.68% Intraday chart for Henan Lingrui Pharmaceutical Co., Ltd. +7.75% +47.87%
Apr. 25 Henan Lingrui Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 25 Henan Lingrui Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Henan Lingrui Pharmaceutical Co., Ltd is a China-based company, principally engaged in the research and development, production and distribution of medicines. The Company's products include emplastrum, tablets, capsules, ointments and others, applied in the treatment of diabetes mellitus, osteoarthritis, gastropathy, cardiovascular and cerebrovascular diseases, respiratory disease, gynecopathy and dermatopathy, among others. The Company distributes its products throughout China, with Henan Province and Beijing as its major markets.

Number of employees: 2,524

Sales per Business

CNY in Million2021Weight2022Weight Delta
Medical and Healthcare
99.8 %
2,675 99.3 % 2,997 99.8 % +12.02%
Others
0.2 %
18 0.7 % 5 0.2 % -71.76%

Sales per region

CNY in Million2021Weight2022Weight Delta
China
100.0 %
2,694 100.0 % 3,002 100.0 % +11.45%

Managers

Managers TitleAgeSince
Wei Xiong CEO
 Chief Executive Officer 40 -
Peng Yu DFI
 Director of Finance/CFO 55 -
Jia Shu Jiang BRD
 Director/Board Member 51 -
Yan Chen BRD
 Director/Board Member 52 -
Guo Xin Feng BRD
 Director/Board Member 35 -
Zi Run Pan BRD
 Director/Board Member 52 -
Xi Zhen Wu BRD
 Director/Board Member 60 06-04-17
Gai Li Mao IRC
 Investor Relations Contact - -
Qiang Ye PRN
 Corporate Officer/Principal 52 -

Members of the board

Members of the board TitleAgeSince
Wei Xiong CEO
 Chief Executive Officer 40 -
Zhi Jun Zhao BRD
 Director/Board Member 53 20-06-04
Xi Zhen Wu BRD
 Director/Board Member 60 06-04-17
Jun Yang BRD
 Director/Board Member 55 23-05-17
Peng Yu DFI
 Director of Finance/CFO 55 -
Jin Li CHM
 Chairman 59 -
Xia Ying Mei BRD
 Director/Board Member 54 20-06-04
Guo Xin Feng BRD
 Director/Board Member 35 -
Yan Chen BRD
 Director/Board Member 52 -
Hui Li BRD
 Director/Board Member 57 20-06-04

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 575,106,322 426,356,733 ( 74.14 %) 7,966,080 ( 1.385 %) 74.14 %

Shareholders

NameEquities%Valuation
Henan Lingrui Group Co., Ltd.
20.77 %
121,817,898 20.77 % 362 M ¥
GF Fund Management Co., Ltd.
5.729 %
33,599,860 5.729 % 100 M ¥
First Seafront Fund Management Co., Ltd.
3.883 %
22,770,142 3.883 % 68 M ¥
HENAN LINGRUI PHARMACEUTICAL CO., LTD.
3.278 %
19,226,445 3.278 % 57 M ¥
Wei Zheng Xiong
2.272 %
13,324,200 2.272 % 40 M ¥
Zhong Ou Asset Management Co., Ltd
1.787 %
10,479,767 1.787 % 31 M ¥
Basic Pension Insurance Fund 1303 Combination
1.199 %
7,030,284 1.199 % 21 M ¥
China Southern Asset Management Co., Ltd.
1.070 %
6,272,487 1.070 % 19 M ¥
Morgan Stanley Huaxin Fund Management Co., Ltd.
0.7128 %
4,180,394 0.7128 % 12 M ¥
Taikang Asset Management Co. Ltd.
0.6668 %
3,910,633 0.6668 % 12 M ¥
NameEquities%Valuation
Xi Zhen Wu
2.806 %
228,000 2.806 % 676 670 ¥

Holdings

NameEquities%Valuation
HENAN LINGRUI PHARMACEUTICAL CO., LTD.
3.28%
 19,226,445 3.28% 57,061,205 $

Company contact information

Henan Lingrui Pharmaceutical Co., Ltd.

666 Jiangjun Road Xin County

465550, Xinyang

+86 37 6298 8888

http://www.lingrui.com
address Henan Lingrui Pharmaceutical Co., Ltd.(600285)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Alternative Medicine

Sales per Business

Ratings for Henan Lingrui Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
25.3
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

1st Jan change Capi.
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+47.87% 1.97B
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+35.04% 5.92B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-15.13% 4.51B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-9.75% 3.15B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
+2.14% 3.1B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-6.82% 2.42B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-7.89% 1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
+0.09% 1.65B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-12.97% 1.53B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD Stock Zhejiang Jolly Pharmaceutical Co.,LTD
+33.40% 1.38B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. 600285 Stock
  4. Company Henan Lingrui Pharmaceutical Co., Ltd.